期刊文献+

辛伐他汀导致肝损害和肌病1例 被引量:2

Liver damage and myopathy induced by simwastatin in 1 case
原文传递
导出
摘要 1例55岁男性患者因急性脑梗塞、2型糖尿病及高脂血症而住院治疗。每天睡前,口服辛伐他汀40 mg。10天后,患者出现全身肌肉酸痛、肌酸激酶和转氨酶显著升高,尿色加深,尿潜血(+)。停用辛伐他汀,予补液、保肝治疗和碳酸氢钠碱化尿液治疗,16天后,全身肌肉酸痛缓解,肌酸激酶和转氨酶恢复正常,遂出院。 A 55-year-old man with acute cerebral infarction,diabetes mellitus and hyperlipidemia,who was given simvastatin 40 mg once daily at bed time for 10 days during the admitted time,he developed aching pain all over the body,and experienced dark urine and occult blood(+)and creatine kinase and alanine transarninase level increased significantly.Simvastatin was withdrawn and the treatment of fluid infusion and hepatoprotection,sodium bicarbonate was given for 16 days,his creatine kinase level and alanine transarninase level decreased to normal,his aching pain all over the body improved markedly and then he was discharged.
作者 王斌 刘桂花
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第1期62-63,共2页 The Chinese Journal of Clinical Pharmacology
关键词 辛伐他汀 肝损害 肌病 simvastatin liver damage myopathy
  • 相关文献

参考文献7

  • 1Ferdinand KC. The importance of aggressive lipid management in patients at risk:evidence from recent clinical trials [ J ]. Clin Cardiol, 2004; 27(6 Suppl. 3):S12- S15.
  • 2Pastermask RC, SmithSC, Jr Bairey - mearz CN, et al. ACC/AHA/ NHLBI clinical advisory on the use and safety of statins[ J]. Circulation,2002; 106: 1024-1028.
  • 3Ucar M, Mjomdal T, Dahlqviso R. HMGCOA reducl ase - in hibitor and myotoxicity [ J ]. Drug Safety,2000 ; 22 : 441 - 447.
  • 4严晓伟.他汀类药物临床应用的安全性[J].基础医学与临床,2006,26(2):123-126. 被引量:25
  • 5路聪哲,武志刚,常艳,于晓红.辛伐他汀加量导致肝损害、肌溶解1例[J].临床荟萃,2009,24(7):589-589. 被引量:3
  • 6Silver MA, Langsjoen PH, Szabo S, et al. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme QIO to reverse that dysfunction [ J ]. Am J Cardiol,2004 ; 94 : 1306 - 1310.
  • 7周颖,袁新婷,鲁云兰.辛伐他汀的不良反应及安全应用[J].药物不良反应杂志,2002,4(5):306-308. 被引量:18

二级参考文献36

  • 1Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ [J]. Guidelines Cireulat, 2004,110: 227 - 239.
  • 2Ssever P, Dahloef B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesteroal concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Ann (ASCOL-LLA) : a multicentre randomised controlled trial[J]. Lancet,2003,361:1149 - 1158.
  • 3Cannon CP, I Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med, 2004,350:1495 - 504.
  • 4LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J]. N Engl J Med, 2005,352: 1425 - 3145.
  • 5Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Third report of the national cholesterel education program (NCEP) expert panel on detection,evaluation and treatment of high blood cholesterol in adults final repert[J]. Circulation, 2002, 106:3143 - 3421.
  • 6Newman CB, Palmer G, Silbershatz, et al. Safety of atorvastatin derived from analysis of 44 completed trials in 9416 patients [J]. Am J Cardiol, 2003, 92:670-676.
  • 7Staffa JA, Chang J, Green L. Cefivastatin and reports of fatal rhabdomyolysis[J] . N Engl J Med, 2002, 346. 539- 540.
  • 8Holdass H, Fellstrom B, Jardine AG, et al. On behalf of the assessment of lescol in renal transplantation study investigators. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial [J]. Lancet, 2003, 361:2024- 2031.
  • 9Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation[ J]. Circulation, 2003, 107:32 - 37.
  • 10Saw J, Steinhubl SR, Berger PB, et al. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled elopidogrel trial[J]. Circulation, 2003, 108: 921- 924.

共引文献42

同被引文献39

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部